ArticleJournal of virology2025

T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses.

April L Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.